Society of Diabetic Nephropathy Prevention Journal of Nephropathology 2251-8363 14 4 2025 10 01 Cardiac amyloidosis in a kidney transplant recipient e27610 e27610 10.34172/jnp.2025.27610 EN Bahareh Marghoob https://orcid.org/0000-0002-1895-2785 Mohammad Hassan Fallahkohan https://orcid.org/0000-0002-3200-399X Journal Article 10.34172/jnp.2025.27610 2025 01 25 2025 04 07 Systemic amyloidosis is a collection of diseases caused by the deposition of protein fibrils in organ tissues, leading to significant morbidity. Cardiac amyloidosis, a rare and debilitating condition, can affect any organ in the body. The two primary types of cardiac amyloidosis are systemic light chain (AL) amyloidosis, which is more common and related to light chain overproduction in the bone marrow, and wild-type transthyretin cardiac amyloidosis (ATTRwt). This case report describes a unique and uncommon case of cardiac amyloidosis observed in a patient following kidney transplant, which was effectively managed using a novel therapeutic regimen.